News &amp; Updates

Patients who develop an acute thrombus in the left ventricle (LV) following myocardial infarction (MI) fare equally well when treated with rivaroxaban as they do with warfarin, as shown in the RIVAWAR study.

Rivaroxaban a game-changer for acute LV thrombus post-MI

15 May 2025

CAR T-cell therapy improves survival in non-Hodgkin lymphoma

Treatment with chimeric antigen receptor T-cell therapies (CAR-TCT) results in significant improvements in overall (OS) and progression-free survival (PFS) among patients with refractory non-Hodgkin lymphoma (NHL) but shows no substantial effect on event-free survival (EFS), reports a study.

CAR T-cell therapy improves survival in non-Hodgkin lymphoma

Unhealthy eating: A trigger for eating disorders, altered neurodevelopment?

A study using data from the longitudinal IMAGEN adolescent cohort sheds light on the association between eating behaviours and eating disorders (EDs) and brain maturation.

Unhealthy eating: A trigger for eating disorders, altered neurodevelopment?

Up-to-date tetanus shots lessen disease severity, improve survival outcomes

Complete childhood vaccinations help reduce the risk of mortality in adult patients with tetanus, according to a study.

Up-to-date tetanus shots lessen disease severity, improve survival outcomes

First-line tislelizumab plus chemo shows benefit in nsq-NSCLC with high PD-L1 expression

First-line treatment with tislelizumab plus chemotherapy showed better survival outcomes and response among patients with locally advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC), particularly those with high PD-L1 expression, compared with chemotherapy alone, according to a subgroup analysis of the phase III RATIONALE-304 trial presented at ELCC 2025.

First-line tislelizumab plus chemo shows benefit in nsq-NSCLC with high PD-L1 expression

World’s first AI model for thyroid cancer diagnosis achieves high accuracy

The world’s first artificial intelligence (AI) model for diagnosis of well-differentiated thyroid cancer, developed by researchers from the University of Hong Kong (HKU), has demonstrated high accuracy in staging and risk classification based on analysis of semi-structured free-text clinical notes.

World’s first AI model for thyroid cancer diagnosis achieves high accuracy

Some women in SG more inclined to undergo osteoporosis assessment, study finds

14 May 2025 by

In Singapore, sociodemographic and clinical factors as well as risk perception and health beliefs influence the willingness of perimenopausal and menopausal women to undergo Bone Mineral Densitometry for osteoporosis assessment, according to a study.

Some women in SG more inclined to undergo osteoporosis assessment, study finds

AML treatment efficacy varies by status, age, cytogenetic risk

Some of the important treatment options for patients with acute myeloid leukaemia (AML) include chemotherapy, targeted therapy, and immunotherapy, but the efficacy of these treatments may vary depending on AML status, age, and cytogenetic risk, according to a study.

AML treatment efficacy varies by status, age, cytogenetic risk

AI model shows potential in reading paediatric elbow radiographs

14 May 2025 by

A deep learning artificial intelligence (AI) model demonstrates good area under the receiver operating characteristic curve (AUROC) and higher sensitivity in the binomial classification of paediatric elbow radiographs when compared to emergency department (ED) physicians, reports a Singapore study.

AI model shows potential in reading paediatric elbow radiographs

Cardio-onco collab may enhance safety of nivolumab anticancer therapy

The safety of nivolumab anticancer therapy may be improved through close collaboration between cardiology and oncology specialists, which can help detect cardiac complications early and manage these conditions effectively, suggests a study.

Cardio-onco collab may enhance safety of nivolumab anticancer therapy